Similarly, the expression levels of both miR-145-5p and MYO6 in tumor tissue is significantly correlated with survival outcomes in several other TCGA patient cohorts, indicating that they could together be useful prognostic biomarkers for different cancers (Supplementary Table S1). The gene discussed is MYO6; the disease is cancer.